Quantinno Capital Management LP Boosts Stake in Astera Labs, Inc. $ALAB

Quantinno Capital Management LP increased its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 49.8% during the first quarter, HoldingsChannel reports. The firm owned 42,150 shares of the company’s stock after buying an additional 14,010 shares during the period. Quantinno Capital Management LP’s holdings in Astera Labs were worth $4,620,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of ALAB. Atreides Management LP increased its holdings in Astera Labs by 2,496.6% in the 4th quarter. Atreides Management LP now owns 1,611,194 shares of the company’s stock worth $268,038,000 after buying an additional 1,549,144 shares in the last quarter. Amundi lifted its stake in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after acquiring an additional 1,319,643 shares during the period. Artisan Partners Limited Partnership purchased a new stake in shares of Astera Labs during the 4th quarter valued at about $148,980,000. Goldman Sachs Group Inc. boosted its holdings in shares of Astera Labs by 189.0% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock valued at $218,419,000 after acquiring an additional 858,693 shares during the last quarter. Finally, State Street Corp grew its stake in shares of Astera Labs by 32.5% in the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after acquiring an additional 760,358 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Stock Up 4.1%

NASDAQ ALAB opened at $331.50 on Friday. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48. The firm has a market cap of $56.82 billion, a price-to-earnings ratio of 164.11, a price-to-earnings-growth ratio of 3.69 and a beta of 3.84. The business has a 50-day moving average price of $360.62 and a 200-day moving average price of $234.58.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 20.46% and a net margin of 30.74%.During the same quarter last year, the business posted $0.44 earnings per share. The business’s quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Research analysts expect that Astera Labs, Inc. will post 1.86 EPS for the current fiscal year.

Insider Activity

In related news, Director Jack R. Lazar sold 10,000 shares of the firm’s stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the completion of the transaction, the director directly owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. This trade represents a 11.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the business’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the completion of the sale, the director owned 1,287,524 shares in the company, valued at $569,098,483.24. This represents a 9.62% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 1,244,395 shares of company stock worth $358,865,571. 10.40% of the stock is owned by corporate insiders.

Analyst Ratings Changes

ALAB has been the subject of several research reports. JPMorgan Chase & Co. boosted their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Royal Bank Of Canada lifted their target price on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research report on Wednesday. Stifel Nicolaus boosted their target price on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research note on Wednesday, June 24th. Citigroup reissued a “buy” rating on shares of Astera Labs in a report on Wednesday, July 29th. Finally, TD Cowen dropped their price target on Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research note on Wednesday. Thirteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $325.25.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs reported record second-quarter revenue of $392.4 million, up 104.5% year over year, while adjusted EPS of $0.80 exceeded the $0.69 consensus estimate. PCIe 6 products generated more than half of sales, highlighting strong demand for connectivity infrastructure used in AI data centers. Astera Labs Q2 Earnings Beat on PCIe 6 and Scorpio Strength
• Positive Sentiment: Management’s third-quarter outlook implies roughly 40% sequential revenue growth and came in above expectations. The Scorpio X-Series switch has entered volume production ahead of schedule, providing another potential growth driver as AI rack-scale deployments expand. ALAB Q2 Earnings Call Puts Scorpio Ramp Ahead of Schedule
• Positive Sentiment: Analysts raised their forecasts after the report. Needham lifted its price target to $425 and retained a Buy rating, while Roth MKM also assigned a Buy rating, signaling confidence in Astera Labs’ AI-connectivity opportunity. Needham Raises Astera Labs Price Target
• Neutral Sentiment: The investment thesis remains tied to selling connectivity “picks and shovels” for rising AI infrastructure spending, but investors are increasingly focused on execution and the sustainability of rapid growth.
• Negative Sentiment: Shares pulled back despite the earnings beat, likely reflecting profit-taking and valuation concerns. With a price-to-earnings ratio above 200 and shares well below their 52-week high, expectations are elevated, leaving limited room for execution setbacks. Astera Labs Post-Earnings Pullback
• Negative Sentiment: Seeking Alpha downgraded the stock, arguing that much of the easy upside may already be reflected in the price. UBS maintained a Hold rating, reinforcing the view that strong fundamentals must continue to justify ALAB’s premium valuation.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.